Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

Dr. Rizwana Quraishi

Dr. Rizwana Quraishi

 

2. Designation: Assistant Professor of Chemistry

 

 

3. Qualifications: M.Sc. (Biochemistry), Ph. D. (Clinical Biochemistry)

 

 

4. Email ID: यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

 

 

5. Field of Interest:

  • Standardization of techniques for health damage assessment (treatment compliance and effectiveness studies)
  • Genetic basis of addictive behaviours.
  • Biochemical and Neurological aspects of addiction (neurotransmitters & immunological response to drugs of abuse)
  • Translational Research: Field applicable and patient friendly assessment techniques like dried blood assays.

 

6. Total number of publications till date: 35

 

 

7. Details of publications since 2006 onwards (the full citation)- these should be divided into journal  articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

  1. Quraishi R, Singh D, Ambekar A, Jain R, Rao R. Gamma gutamyl transferase measurement in dried serum spots. Alcohol Clinical & Experimental Research, 2018; 42 (S2), P1-1-48: 24A. 
  2. Chatterjee B, Quraishi R, Rao R. Genetic aspects of addictive disorders. Indian J Psychiatry 2018, 60 (supplement 1): S26.
  3. Jain R, Quraishi R, Verma A. Evaluation of dried urine spot method to screen cotinine among tobacco dependents: An exploratory study. Indian J Psychol Med. 2017; 39(4): 469-474.
  4. Jain R, Quraishi R, Ambekar A, Verma A, Gupta P. Dried urine spots for detection of benzodiazepines. Indian J Pharmacol. 2017; 49 (6): 465-469.
  5. Quraishi R, Jain R, Mishra AK, Ambekar A. Association of ankyrin repeats 7 kinase domain containing ANKK1gene polymorphism with co-morbid alcohol & nicotine dependence: A pilot study from a tertiary care treatment centre in north India. Indian J Med Res. 2017; 145 (10): 33-38.  
  6. Quraishi R, Jain R, Ambekar A. Hematological profile of alcohol dependent subjects: Report from a tertiary care treatment centre in India. Int J Pharma Res Health Sci. 2016; 4 (5): 1420-1423.  
  7. Quraishi R, Lakshmy R, Mukhopadhyay AK, Jailkhani BL. Transaminase extraction and stability from dried serum samples. Sch. J. App. Sci. 2014; 2 (1B): 169-170.   
  8. Quraishi R and Jain R. ANKK1/Taq A1 genotyping from dried blood stored on filter paper among alcohol and nicotine dependent subjects. British Biomedical Bulletin 2014; 2 (1): 263-266.
  9. Quraishi R, Jain R, Balhara YPS. Profile of Nicotine Use among Alcohol Dependent Patients Visiting a Tertiary Care Center in North India. Indian J Psychol Med. 2014; 36(2):174-8.
  10. Jain R, Quraishi R, Majumder P, and Pattanayak RD. Comparison of self-report and biological measures for alcohol, tobacco and illicit drug use in consecutive alcohol dependent patients visiting a tertiary care centre. Journal of Substance Use 1-9, Posted online on 19 April 2012.
  11. Quraishi R, Jain R, Pattanayak RD. Laboratory Profile of current Injecting Drug Users seeking treatment at a tertiary care centre in India: What do the regular blood tests and HIV screening say? Addict Addictive Disorders & Their Treatment 2012, 11 (4): 206–211.
  1. Quraishi R, Jain R, Anish PK. Naltrexone level and biochemical profile of opiate dependent patients on Naltrexone Maintenance Programme: A pilot study. Addictive Disorders and Their Treatments.Published ahead of print.     10.1097/ADT.0b013e31827a1ede
  2. Quraishi R, Jain R, Ambekar A. The use of dried blood spot samples in screening drugs of abuse. Pharmacology & Pharmacy 2013; 4: 152-159.
  3. Quraishi R, Lakshmy R, Mukhopadhyay AK, and Jailkhani BL.Analysis of the stability of urea in dried blood spots collected and stored on filter paper”. Annals of Laboratory Medicine 2013; 33: 1-3.
  4. Quraishi R, Pattanayak RD, Jain R, Dhawan A. A  Descriptive Study of Clinical, Hematological and Biochemical Parameters of Inhalant Users Seeking Treatment at a Tertiary Care Centre in India. Indian J PsycholMed2013; 33: 1-3.
  5. Quraishi R, Jain R, Chatterjee B, Verma A. Laboratory profile of cannabis dependent treatment-seeking population at a tertiary care centre in India. Int J High  RiskBehav Addict 2013;2(3): 107-11.
  6. Chatterjee B, Quraishi R, Jain R.Socio-demographic and drug use characteristics of treatment-seeking cannabis users at a tertiary care centre in India”.Addictive Disorders and Their Treatments2013; 33: 1-3.
  1. Quraishi R, Lakshmy R,Mukhopadhyay AK, Jailkhani BL. Creatinine measurement and stability in dried Serum. J DiabetSciTechnol 2012 Jul 1; 6(4):988-9
  2. Quraishi R, Lakshmy R, Luthra K, Mukhopadhyay AK, Jailkhani BL. Apo E Genotyping from blood stored on filter paper.The Indian Journal of Medical Research 2012; 135 (3): 318-321
  3. Quraishi R, Lakshmy R, Prabhakaran D, Irshad M, Mukhopadhyay AK, Jailkhani BL. Effect of Storage Temperature on Cholesterol Measurement from Dried Blood. The Indian Journal of Medical Research 2007, 126: 228-229.
  4. Quraishi R, Lakshmy R, Prabhakaran D, Mukhopadhyay AK, Jailkhani BL.Use of filter paper stored dried blood for measurement of triglyceride. Lipids in health and disease 2006, 5: 20.

Book Chapters:

  1. RizwanaQuraishi, Raka Jain, Atul Ambekar. Dried Blood Spots for Testing Drugs of Abuse. In: Kim Wolff (Ed). Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation. The Royal Society of Chemistry, Cambridge, UK, 2017: pp 127-146. ISBN: 978-1-78262-157-7
  2. Rizwana Quraishi and Atul Ambekar. Genetics of alcohol use disorder. In: Dihingia S &Bhuyan D (Ed). Psychiatry Update. Indian Psychiatry Society, Dibrugarh and Psychiatrists of Dibrugarh, Assam. First Edition, 2018: pp 221-242. ISBN: 978-93-5311-908-9.

 

8. Presentations made at scientific meetings/ conferences/ workshops:

  1. Quraishi R, Singh D, Ambekar A, Jain R, Rao R. Gamma gutamyl transferase measurement in dried serum spots. Poster presented at the 19th congress of international society for biomedical research on alcoholism (ISBRA2018), 9-13 Sept 2018 in Kyoto, Japan.
  2. Quraishi R, Chatterjee B and Rao A. Genetics of alcohol and opioid dependence: prevalence, association and implications in treatment outcome.  Presented symposium at 3rd Global conference of Biological Psychiatry, 23-26 Aug 2018 in Grand Hyatt, Mumbai.
  3. Chatterjee B, Quraishi R, Rao R. Genetic aspects of addictive disorders. Symposium accepted at Annual National Conference of Indian Psychiatric Society 5-8 Feb 2018 Ranchi, Jharkhand.
  4. Quraishi R. Genetic predictors and moderators of treatment research in substance use (alcohol use disorders). Symposium presented at National Conference on Addiction Psychiatry 27-29 Nov 2017, AIIMS, Delhi.
  5. Raka Jain, Quraishi R, ArpitaVerma, Atul Ambekar. Evaluation of Dried urine spot method for detection of BZD among substance users. International Association of Medico Legal Experts (IAMLE), Jan 2016.
    1. Quraishi R, Jain R, Ambekar A, Verma A, Gupta P. Feasibility of using filter paper as a matrix for drug screening in urine of substance users. Presented at 49th Annual Conference of Indian Pharmacological Society 21-23 Oct 2016.
    2. Quraishi R, Jain R, Bera SC, Ambekar A. Association of alcohol use pattern with liver enzyme levels: report from a tertiary care treatment centre in India.  Presented at World association of Social Psychiatry, Nov, 2016.
    3. Raka Jain, Quraishi R, ArpitaVerma. Evaluation of Dried urine spot method for detection of cotinine among Tobacco users. National Institute on Drug Abuse (NIDA) International Forum, June 2015.

9. Investigator in funded projects along with year completed:

 

  1. Feasibility of transporting blood/serum samples onto filter paper to screen for biomarkers of harmful alcohol use among opioid dependent patients on agonist maintenance treatment: A pilot study in community setting. (PI) (AIIMS Intramural funding) (2016-18)    

 

10. Investigator in non-funded projects along with year and title completed:

  1. Effect of smoking on Platelets Monoamine Oxidase B activity levels in Opioid Dependent Patients on Maintenance Treatment: An Exploratory study. (2016-17)
  2. A Comparative evaluation based on clinical and laboratory profile of HIV screened positive and negative treatment-seekers from a tertiary care treatment centre: A retrospective chart analysis study. Departmental study. (2014-16)
  3. Association of COMT (catechol-O-methyltransferase) polymorphism and comorbid alcohol and nicotine dependence among treatment seekers in India. A Pilot Study. Departmental study. (2014-16)
  4. Estimation of nicotine in urine samples spotted on filter paper in substance users.(2013-14)
  5. 5.       Evaluation of compliance in patients receiving naltrexone for long term management of opioid dependence.(2012-14)
  6. Assessment of biochemical and hematological profile of opioid dependent patients receiving Buprenorphine / Buprenorphine –naloxone combination.(2012-14)

11. Investigator in funded projects along with year and title ongoing:

 

  1. A functional polymorphism of dopamine beta hydroxylase gene and disulfiram treatment response in patients with alcohol dependence: A pilot exploratory study. (2018-20)

 

12. Investigator in non-funded projects along with year and title ongoing:

  1. To explore and compare the association of various demographic, clinical and laboratory factors with Delirium Tremens (DT) among patients with Alcohol Dependence (AD), admitted with and without a diagnosis of DT, based upon review of clinical records. Departmental study. (2017 ongoing)

13. Co-investigator in funded projects along with year and title completed:

  1. Feasibility of transporting urine samples of drug users on filter paper for screening drugs of abuse: A pilot exploratory study. (Co-PI) (ICMR funded)

 

14. Co- investigator in non-funded projects along with year and title ongoing: None

15. Co- investigator in funded projects along with year and title ongoing:

  1. Biomarkers of Lithium response in Bipolar disorder: assessment of the clinical markers, peripheral blood based markers and structural neuroimaging markers (pertaining to gray matter volume) in individuals with bipolardisorder on long-term lithium prophylaxis. (2017 Ongoing)
    1. Detection of New Psychoactive Substancesamong Substance Abuse Treatment Seekers in India: A Multi-centric Study. (2017 ongoing)

16. Co- investigator in non-funded projects along with year and title ongoing: None

17. Thesis supervised for MD/ PhD

- as guide (number only): None

 

-as co-guide (number only): Two

Dr Piyali Mandal

 

 

Dr Piyali Mandal
MD (Psychiatry)

यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.
Contact details: 01126593236


 

FIELDS OF INTEREST
Substance use among women and adolescent population

Total number of publications till date > 30

  1. Mandal P, Parmar A, Ambekar A, Dhawan A. Substance use among treatment seeking Indian adolescent girls: Are they unique? Asian J Psychiatr. 2019 Mar;41:17-19. doi: 10.1016/j.ajp.2019.03.007. Epub 2019 Mar 6
  2. Chawla N, Mandal P, Chatterjee B, Dhawan A. Tramadol associated pica: A case report. Psychiatry clin Neurosci. 2019;73(1):43. doi: 10.1111/pcn.12789. Epub 2018 Dec 2.
  3. Mandal P, Dhawan A. Interventions in individuals with specific needs. Indian J Psychiatry2018,60(8): 553-58
  4. Dhawan A, Mandal P. Preventive strategies for substance use. Indian J Soc Psychiatry2017,33(2):108-11
  5. Ambekar A, Parmar P. Tirthani S, Mandal P. Profile of women substance users seeking treatment at tertiary care treatment centre: A retrospective chart review study. J Subst Use 2017, 22( 5): 507-10.doi.10.1080/14659891.2016.1255792
  6. Mandal P, Parmar P. Tirthani S, Ambekar A. Profile of elderly women seeking treatment for substance use disorders at a tertiary care treatment centre. J Subst Use 2017,22(3):353-55.doi.org/10.1080/14659891.2016.1217092
  7. Parmar A, Mandal P, Tripathi M, Sagar R Escitalopram Induced Hyponatremia. ASEAN J Psychiatry 2016, 17 (2): 254-57
  8. Gupta P, Mandal P, Singh D, Pattanayak RD, Bhargava R, Anju Dhawan A. Detection of Optic Neuropathy and 3-month Follow-up of an Adolescent Inhalant User: Are we Paying Enough Attention? Indian J Psychol Med. 2016; 38(5): 486–88.doi: 10.4103/0253-7176.191390
  9. Rao R, Mandal P , Gupta R, Ramshankar P , Mishra A , Ambekar A , Jhanjee S, Dhawan A. Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India. J Subst Abuse Treat. 2016;(61):13–7
  10. MandalP,Prakash S."Tramadol: a good option for management of opioid withdrawal syndrome in developing countries." J Subst Use, 2016,21(4) : 339–40
  11. Pal A, Parmar A, Mandal P, Sagar R. A case of persistent delusional disorder: Role of dimensions of delusion reappraised. J Mental Health Human Behav. 2016; 21(1): 64-5
  12. Mandal P, Jain R, Jhanjee S, Sreenivas V. Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study. Indian J Psychol Med. 2015 Jul-Sep; 37(3): 299–304. doi: 10.4103/0253-7176.162944
  13. Prakash S, Mandal P. Is dhat syndrome indeed a culturally determined form of depression? Ind J Psychol Med 2015; 37(1):108-9
  14. Prakash S, Mandal P. Drug trials in psychiatry: Methodological issues. Asian J Psychiatry. 2014; 8:109-10.
  15. Prakash S, Mandal P. Is the DSM-5 position on dhat syndrome justified?Asian J Psychiatry. 2014; 12:155-57.DOI: http://dx.doi.org/10.1016/j.ajp.2014.08.006
  16. Prakash S, Mandal P. Psychiatry’s dilemma: A poorly valid symptom based classification versus a yet infantile neuroscience based classification. Asian J Psychiatry. 2014;13:83-4
  17. Prakash S, Mandal P. Dhat syndrome: An extremely unusual presentation. World Cul Psych Res Rev World Cultural Psychiatry Research Review 2014; 9 (3): 140-3
  18. Prakash S, Mandal P. Medically Unexplained Somatic Symptoms – Diagnostic and Treatment Issues in the Indian Subcontinent. Am J Psychiatry.2014; 171(11):1158-9.
  19. Gupta A, Mandal P, Rachna Bhargava R, Pattanayak RD, Sagar R, Dhawan A.Marked Exacerbation of ADHD After Onset of Inhalant Use: A Case Report. J Neuropsychiatry Clin Neurosci. 2014 26(4): E6-E7
  20. Mandal P, Prakash S, Sagar R. Primary caregivers of schizophrenia outpatients: burden and its correlates. Delhi Psychiatry J. 2014; 17(2):343-8.
  21. Prakash S, Mandal P.Is the DSM-5 position on dhat syndrome justified? Asian J psychiatry. 2014, 27(12):155-7.
  22. Mandal P, Prakash S. Stigma of mental disorders and role of nursing professionals: A developing country perspective. J nursing & care. 2014; 3(5):190. http://dx.doi.org/10.4172/2167-1168.1000190
  23. Mandal P, Prakash S. Methodological considerations in studying psycho-social aspects of suicide. Ind J psychiatry. 2014; 56 (2):208-9.
  24. Prakash S, Mandal P. Improving somatic health in severe mental illness. Acta Psychiatr Scand. 2014; 129(3):236-7.
  25. Prakash S, Mandal P. Natural Disasters, Armed Conflict, and Public Health. N Eng J Med. 2014; 370(8):783.
  26. Srivastava P, Mandal P, Mehta M, Sagar R. Psychological Intervention in a Case of Bulimia Nervosa: A Case Report. Psychol Studies. 2014; 59(1):68–75.
  27. Prakash S, Mandal P. Culture bound syndromes: Nosological and management issues. Ind J Psychiatry 2014; 56(1):99.
  28. Mandal P, S. Arumuganathan, Rajesh Sagar, Pakhi Srivastava. A Classical Case of Bulimia Nervosa from India. Indian J Psychol Med .2013; 35 (3): 309-10.
  29. Mandal P, Prakash S, Deb KS. Schizophrenia caregivers’ burden: Need to look deeper. Asian J Psychiatry. 2013 Oct; 6(5):428.
  30. Mandal P, Pal A, Sagar R. Common mental disorders-A review. J Mental Health Human Behav 2013,8(2):6-14
  31. Prakash S, Mandal P, Sagar R. Paroxetine in the treatment of recurrent brief depressive disorder. J Pharmacol Pharmacother. 2013; 4(4): 288–290.
  32. Thapa R, Mallick D, Mandal P, Ghosh A. Neuroblastoma masquerading as juvenile idiopathic arthritis. Indian J Pediatrics. 2007; 74(4): 421-422

Abstract published in indexed journals

  1. Parmar A, Mandal P, Ambekar A, Dhawan A. Substance use among female adolescents seeking treatment: A study from a tertiary care substance use treatment centre. Indian J Soc Psychiatry. 2018.Accepted for publication
  2. Mandal P, Varshney M, Das N, Dhawan A. Profile of adolescent opioid users seeking treatment at a national level addiction treatment centre. Indian J Psychiatry. 2018; 60: S-151
  3. Jhanjee S, Jain R, Mandal P. E-cigarettes in adolescents: Issues and challenges. Indian J Soc Psychiatry. 2018; 60:S-43
  4. Mandal P, Kuppili PP, Bhargava R, Pattanayak RD, Dhawan A. Clinical profile and retention on pharmacological treatment among opioid dependent adolescents: A retrospective chart review. The Indian J Ped. 2017;SS-1:118
  5. Sharma S, Mandal P, Mongia M, Ambekar A. Barriers to Treatment and Psychosocial Complications of Prescription Opioid Dependence in Women in Indian Context: A Case Report and Brief Review. Indian J Soc Psychiatry 2017, 33: S-14
  1. Kamran A, Garg H, Varshney M, Agrawal A, Dayal P, Mandal P, Ambekar A. Iatrogenic Opioid Use Disorder In A Young Woman: A Case Report With Unique Clinical Characteristics. Indian J Psychiatry. 2017; 59(S2): 239

 

  1. Shah B, Yadav P, Ambekar A, Mandal P. Gender Sensitive Substance Use Treatment Services: Challenges and Opportunities. Indian J Psychiatry 2016;58(S1): S41
  2. Bhargava R, Mandal P, Gupta A, Dhawan A. Psychosocial Determinants of Drop-Out From Treatment At Child & Adolescent Clinic of National Drug Dependence Treatment Centre. Indian J Psychiatry 2016;58(S1): S-121
  3. Jhanjee S, Jain R, Chatterjee B, Mandal P. E-Cigarettes Use: Is it an Acceptable Alternative? Indian J Soc Psychiatry 2016.32(4): 386
  4. Mandal P, Chatterjee B, Sagar R, Prakash S. Stigma Towards Mentally Ill Among Health Care Staffs in India and Way Forward. Indian J Soc Psychiatry 2016.32(4):413
  5. Parmar A, Mandal P, Therthani S, Ambekar A. A Retrospective Chart Review of Female Substance Users Attending Outpatient Clinic at Tertiary Care Drug Dependence Treatment Centre in India. Indian J Soc Psychiatry 2016.32(4):455
  6. Kuppili PP, Bhargava R, Mandal P, Mishra AK, Gupta A, Dhawan A. Correlates of treatment retention among children & adolescent substance users seeking treatment in tertiary hospital in North India. Indian J Soc Psychiatry 2016.32(4):459
  7. Chatterjee B, Mandal P, Sagar R, Kumar N. Attitude towards mentally ill among nursing Professionals: Evidence from a Tertiary Care General Hospital. Indian J Psychiatry 2015;57(S): 92
  8. Krishnan V, Ambekar A, Mandal P, Rao R, Mishra AK. Outcomes on buprenorphine-naloxone at a tertiary care substance use facility: a retrospective chart review. Indian J Psychiatry 2015;57(S):102
  9. Jhanjee S, Mandal P, Singh D. Tobacco use in opioid-dependent patients on buprenorphine-naloxone treatment. Ind J Psychiatry Jan 2014; 56 (Suppl 1): S19–S20
  10. Mandal P, Jain R, Jhanjee S, Sreenivas V. Barriers of tobacco cessation among Indian buprenorphine-naloxone maintained patients. Alcohol alcohol. 2014; 49(suppl1): i6.doi: 10.1093/alcalc/agu052.19
  11. Chatterjee B, Sagar R, Mandal P, Kumar N. Mental illness: Who do the professional blame? Ind J Psychiatry Jan 2013; 55(S 1): S61–S62

Abstracts published in conference abstract book/ International abstract data base

  1. Mandal P. E-cigarette use: what is the raging debate? In: The proceedings of World congress of Mental Health.2017 November 2-5;New Delhi, India.
  2. Mandal P. Women and drug use: addressing the treatment needs. In: Abstracts of First national conference on Addiction Psychiatry; 2017 November 27-29;New Delhi, India.
  3. Chawla N, Mandal P, Chatterjee B, Dhawan A. Tramadol induced pica. In: Abstracts of First national conference on Addiction Psychiatry; 2017 November 27-29;New Delhi, India
  4. Mandal P. The role of the glutamate and cannabinoid neurotransmitter systems in the nicotine dependence and their treatment implications. In abstracts of 34th Annual meeting of Indian Academy of Neurosciences; 2016 October 19-21; National Brain Research Centre, Manesar, India
  5. Mandal P, Dhawan A, Bhargava R, Sharma S. A retrospective study of factors associated with management of adolescent substance use. In: the proceedings of the 7th Congress of the Asian Society for Child and Adolescent Psychiatry and Allied Professions (ASCAPAP) 2013 September 14-18, New Delhi, India
  6. Mandal P, Chatterjee B, , Rakesh VR, Kumar N, Sagar R. Community Attitude towards Mentally and Their Treatment among Nursing Professionals in a Tertiary Care General Hospital. In: Abstracts of the 4th World Congress of Asian Psychiatry; 2013 August 20-23; Bangkok, Thailand
  7. Mandal P, Jain R, Jhanjee S, Sreenivas V. Tobacco use in opioid-dependent subjects on buprenorphine-naloxone maintenance treatment. In: Abstract database of NIDA International forum 2013. June 14 -17;San Diego, USA

Presentations made at scientific meetings/ conferences/ workshops
International

    1. 22nd World Congress of Social Psychiatry, 2016 November 30-December 4, New Delhi, India
    2. The 16th International Society of Addiction Medicine Annual Meeting, 2014 October 2-6, Yokohama, Japan
    3. 7th Congress of the Asian Society for Child and Adolescent Psychiatry and Allied Professions (ASCAPAP) 2013 September 25-28, New Delhi, India
    4. NIDA International forum; 2013 June 14 -17;San Diego, CA, USA
    5. 4th World Congress of Asian Psychiatry; 2013 August 20-23; Bangkok, Thailand

National

  1. First National conclave on Psychological trauma, Child protection and Mental Health, 2018 March 27-28; New Delhi, India.
  2. First national conference on Addiction Psychiatry, 2017 November 27-29;New Delhi, India
  3. Annual National conference on Addiction Psychology. 2017 September 7-8, Ghaziabad, India
  4. 34th Annual meeting of Indian Academy of Neurosciences; 2016 October 19-21; National Brain Research Centre, Manesar, India
  5. 12th Biennial Conference of the Indian Association for Child and Adolescent Mental Health, 2013 September 25-28, New Delhi, India
  6. 65th Annual National Conference of Indian Psychiatric Society. 2013 January 10-13, NIMHANS, Bangalore, India
  7. 64th Annual National Conference of Indian Psychiatric Society. 2012 January 19-22, Kochi, India
  8. 63rd Annual National Conference of Indian Psychiatric Society. 2011 January 16-18, New Delhi, India
  9. 62nd Annual National Conference of Indian Psychiatric Society. 2010 January 17-20, Jaipur, India

Invited Lectures/ CME

  1. Delivered invited lecture titled "Women in addiction; issues, concerns and service gaps" in the 7th National Federation of Indian NGOs for Drug Abuse prevention (FINGODAP) conferenceon 30th March, 2019, in Delhi
  2. Training of Medical Officers of NCT of Delhi on management of Adolescent Substance Use on 23rd January and 2nd Februay, 2018
  3. Training of teachers of senior schools under Jamia Milia Islamia on “Skills of dealing with Adolescents facing substance abuse” on 22nd December, 2017
  4. Delivered invited lecture titled “Gender sensitive interventions: An overview” in the national CME on “Emerging Issues in Substance Use Disorders” on 22nd July, 2017 at NAMS Auditorium, New Delhi
  5. Training session on substance abuse problem for police personnel from Central Detective Training School, Ghaziabad on7.3.2017 at NDDTC
  6. Organized symposium on “Women and drug use” on 14th annual day NDDTC on 13th April,2017 . The title of presentation was “Addiction treatment services for women: a need of the hour”
  1. Funded projects
    Principal investigator for the project titled “Psycho-social correlates of drug use among attendees of Women’s Clinic of National Drug Dependence treatment Centre” under AIIMS Intramural funding ( 2017)
  1. ICMR financial assistance for MD thesis (2009)
  2. ICMR (International travel award) (2013)
  3. National Institute of Drug Abuse (Early career investigator poster award) (2013)
  4. World Congress of Asian Psychiatry- Travel award (2013)
  5. CSIR- Travel award (2013)
  6. ICMR-Travel award (2013)
  7. DST- Travel Award (2014)
  8. WHO-ISAM Grants-In-Aid-Of-Travel Fellowship -International Society of Addiction Medicine (2014)



21st Annual Meeting of International Society of Addiction Medicine to be held in New Delhi, India from 13th to 16th November 2019

 

21st Annual Meeting of International Society of Addiction Medicine to be held in New Delhi, India from 13th to 16th November 2019. The theme of the conference is "Addiction in a Rapidly Changing World". We look forward to this opportunity to meet colleagues for shared learning, and a rich social and cultural experience. The conference is being organised by the Department of Psychiatry & National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Key dates

Proposal Submission deadline for Symposium/ Workshop: 30th April, 2019 (Midnight; Indian Standard Time)

Abstract Submission deadline for Oral Communication / Posters: 30th June, 2019 (Midnight; Indian Standard Time)

Please click here for detail

 

NDDTC, AIIMS celebrates its 16th Annual Day on 15th April 2019

 

NDDTC, AIIMS celebrates its 16th Annual Day on 15th April 2019

The 16th Annual Day of National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi was celebrated at NDDTC, Ghaziabad on 16th April 2019.  Mr. Deves Deval, Director, DDAP, MOH&FW; Prof.RandeepGuleria, Director, AIIMS, New Delhi,  Dr. DK Sharma, MS, AIIMS, New Delhi. Mr. Veerendra Mishra, Director, NISD were the dignitaries for the function. Prof (Dr.) Rakesh Chadda, Chief NDDTC and Head Department of Psychiatry, AIIMS presented the Annual Report for the year 2018- 2019 highlighting the achievements of the centre. Organizing Secretary, Prof(Dr.) Atul Ambekar presented the findings of recently conducted 2nd“National Drug Use Survey of India”. Textbook of “Basics of Addiction Psychology” was also released on this occasion.

AIIMS, New Delhi launches India’s first ever Mobile Methadone Dispensing Van

 

AIIMS, New Delhi launches India’s first ever Mobile Methadone Dispensing Van

The National Drug Dependence Treatment Centre (NDDTC), AIIMS has initiated a new service – delivery of methadone through a mobile van in East Delhi. The new service delivery was inaugurated by the AIIMS Director, Prof. Randeep Guleria on 22 March 2019 in the presence of officers from National AIDS Control Organisation (NACO), United Nations Office on Drugs and Crime (UNODC), and the Director General Health Services, Govt. of Delhi. Representatives from NGOs, and drug user community also attended the inauguration event.
Opioid Addiction is a significant problem in India. The recently released report of National Survey last month estimated that India has about 28 Lakh people affected by addiction to opioids such as heroin, opium and various pharmaceutical products. These people require medicines such as methadone or buprenorphine for treatment of opioid addiction. However, there are very few treatment centres providing these medicines, while the need is very high. It is estimated that less than two percent of the population addicted to opioids in India is receiving this treatment, which is recommended by various UN bodies and the World Health Organization (WHO).
Since methadone is a highly regulated medicine it is only provided as daily observed treatment. This medicine is available in just about a dozen cities in India. “Patients often find it difficult to come to the clinic daily to receive methadone, which leads to patients dropping-out of treatment midway”, informed Dr. Ravindra Rao, in-charge of the methadone clinic. The mobile methadone dispensing unit plans to bridge this gap and improve retention of patients into treatment enabling them to work and lead a healthier life. Currently, such dispensing vans or buses are available in few select developed countries in the world, such as USA, Portugal, Spain, Canada and Netherlands. With the launch of mobile delivery of methadone, India joins this elite club. In fact, India is the first country in the South Asian Region to initiate these services.
The van will be parked at strategic places in East Delhi and adjoining areas for fixed time period in the day, where the patients can come and receive their medicine without having to travel to the main clinic. “In the trial run for last two weeks we already have more than two dozen patients enrolled in the facility and the response is very encouraging” informed Dr. Rao. This number is expected to reach about 100 patients per day, very soon. Based on the success of this initiative, this new approach can be scaled-up in different parts of the country.

For Detail Please Click Here

Top of Page